AU2002212863A1 - Stable pharmaceutical form of an anticancer drug - Google Patents

Stable pharmaceutical form of an anticancer drug

Info

Publication number: AU2002212863A1
Authority: AU; Australia
Prior art keywords: anticancer drug; pharmaceutical form; stable pharmaceutical; stable; anticancer
Prior art date: 2000-10-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002212863A

Inventor

Iwona Czarnecka

Stanislaw Janicki

Wladyslaw Karas

Zdzislaw Mroczek

Malgorzata Sznitowska

Andrzej Tyrala

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

INSTYTUT CHEMII ORGANICZNEJ PAN

Akademia Medyczna

Warszawskie Zaklady Farmaceutyczne Polfa SA

Original Assignee

INST CHEMII ORGANICZNEJ PAN

Akademia Medyczna

Warszawskie Zaklady Farmaceutyczne Polfa SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-31

Filing date

2001-10-19

Publication date

2002-05-15

2001-10-19 Application filed by INST CHEMII ORGANICZNEJ PAN, Akademia Medyczna, Warszawskie Zaklady Farmaceutyczne Polfa SA filed Critical INST CHEMII ORGANICZNEJ PAN

2002-05-15 Publication of AU2002212863A1 publication Critical patent/AU2002212863A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Oncology (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AU2002212863A 2000-10-31 2001-10-19 Stable pharmaceutical form of an anticancer drug Abandoned AU2002212863A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
PL343615A PL203300B1 (en)	2000-10-31	2000-10-31	Stable pharmacological form of anticarcinogenic drug and method of obtaining such drug in that form
PL343615		2000-10-31
PCT/PL2001/000082 WO2002036582A1 (en)	2000-10-31	2001-10-19	Stable pharmaceutical form of an anticancer drug

Publications (1)

Publication Number	Publication Date
AU2002212863A1 true AU2002212863A1 (en)	2002-05-15

Family

ID=20077651

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002212863A Abandoned AU2002212863A1 (en)	2000-10-31	2001-10-19	Stable pharmaceutical form of an anticancer drug

Country Status (15)

Country	Link
EP (1)	EP1363892B1 (en)
AU (1)	AU2002212863A1 (en)
BG (1)	BG65985B1 (en)
CZ (1)	CZ300836B6 (en)
DE (1)	DE60122384T2 (en)
HK (1)	HK1060733A1 (en)
HU (1)	HUP0303089A3 (en)
LT (1)	LT5069B (en)
PL (1)	PL203300B1 (en)
RU (1)	RU2236227C1 (en)
SI (1)	SI21138B (en)
SK (1)	SK287850B6 (en)
UA (1)	UA75620C2 (en)
WO (1)	WO2002036582A1 (en)
ZA (1)	ZA200303276B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1596250A (en) *	2001-11-30	2005-03-16	布里斯托尔-迈尔斯斯奎布公司	Paclitaxel solvates
ATE427943T1 (en)	2003-12-12	2009-04-15	Quiral Quimica Do Brasil	METHOD FOR PRODUCING ANHYDROUS AND HYDRATED PHARMACEUTICAL ACTIVE INGREDIENTS (APIS); STABLE PHARMACEUTICAL COMPOSITIONS PRODUCED FROM THESE AND USES FOR THESE COMPOSITIONS
AR054215A1 (en) *	2006-01-20	2007-06-13	Eriochem Sa	A PHARMACEUTICAL FORMULATION OF A TAXANE, A SOLID COMPOSITION OF A LIOFILIZED TAXAN FROM AN ACETIC ACID SOLUTION, A PROCEDURE FOR THE PREPARATION OF A SOLID COMPOSITION OF A TAXANE, A SOLUBILIZING COMPOSITION OF A LIOFILIZED TAXANE AND AN ELEMENTARY KIT
US20080262078A1 (en) *	2007-04-20	2008-10-23	Namdeo Alok B	Pharmaceutical Compositions
CN110437179A (en) *	2019-08-22	2019-11-12	江苏红豆杉药业有限公司	A kind of taxol monocrystalline crystal and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2678833B1 (en) *	1991-07-08	1995-04-07	Rhone Poulenc Rorer Sa	NEW PHARMACEUTICAL COMPOSITIONS BASED ON DERIVATIVES OF THE TAXANE CLASS.
TW406020B (en) *	1993-09-29	2000-09-21	Bristol Myers Squibb Co	Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
CA2163837C (en) *	1994-12-13	1999-07-20	Robert K. Perrone	Crystalline paclitaxel hydrates

2000
- 2000-10-31 PL PL343615A patent/PL203300B1/en not_active IP Right Cessation
2001
- 2001-10-19 CZ CZ20031421A patent/CZ300836B6/en not_active IP Right Cessation
- 2001-10-19 SK SK629-2003A patent/SK287850B6/en not_active IP Right Cessation
- 2001-10-19 RU RU2003116136/15A patent/RU2236227C1/en not_active IP Right Cessation
- 2001-10-19 UA UA2003055025A patent/UA75620C2/en unknown
- 2001-10-19 SI SI200120060A patent/SI21138B/en not_active IP Right Cessation
- 2001-10-19 WO PCT/PL2001/000082 patent/WO2002036582A1/en active IP Right Grant
- 2001-10-19 EP EP01981204A patent/EP1363892B1/en not_active Expired - Lifetime
- 2001-10-19 DE DE60122384T patent/DE60122384T2/en not_active Expired - Lifetime
- 2001-10-19 HU HU0303089A patent/HUP0303089A3/en unknown
- 2001-10-19 AU AU2002212863A patent/AU2002212863A1/en not_active Abandoned
2003
- 2003-04-25 BG BG107764A patent/BG65985B1/en unknown
- 2003-04-29 ZA ZA200303276A patent/ZA200303276B/en unknown
- 2003-05-05 LT LT2003031A patent/LT5069B/en not_active IP Right Cessation
2004
- 2004-05-25 HK HK04103719A patent/HK1060733A1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
RU2236227C1 (en)	2004-09-20
ZA200303276B (en)	2004-04-21
LT5069B (en)	2003-11-25
PL343615A1 (en)	2002-05-06
HUP0303089A3 (en)	2005-02-28
DE60122384T2 (en)	2007-08-16
PL203300B1 (en)	2009-09-30
BG65985B1 (en)	2010-08-31
BG107764A (en)	2004-07-30
SK287850B6 (en)	2012-01-04
DE60122384D1 (en)	2006-09-28
WO2002036582A1 (en)	2002-05-10
CZ20031421A3 (en)	2004-06-16
SI21138A (en)	2003-08-31
UA75620C2 (en)	2006-05-15
CZ300836B6 (en)	2009-08-19
SK6292003A3 (en)	2004-08-03
HUP0303089A2 (en)	2003-12-29
EP1363892B1 (en)	2006-08-16
LT2003031A (en)	2003-09-25
EP1363892A1 (en)	2003-11-26
SI21138B (en)	2006-10-31
HK1060733A1 (en)	2004-08-20

Similar Documents

Publication	Publication Date	Title
AU2002216701A1 (en)	2002-05-27	Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
MXPA02003596A (en)	2003-10-14	Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation.
AU2331801A (en)	2001-07-09	Improved pharmaceutical compositions for poorly soluble drugs
IL149186A0 (en)	2002-11-10	Pharmaceutical compositions providing enhanced drug concentrations
AU2002357012A1 (en)	2003-06-10	Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
AU2001235691A1 (en)	2001-08-27	Use of paullone derivatives for making medicines
AU4357800A (en)	2000-11-02	Intracellular pharmaceutical targeting
AU2002239397A1 (en)	2002-06-18	Drug formulation having improved oral tolerability
AU1724301A (en)	2001-07-09	Hydrogel-driven layered drug dosage form
AU2001234114A1 (en)	2001-09-03	Drugs containing combined active ingredients
AU2001270778A1 (en)	2002-01-21	Production, stabilisation and use of reduced forms of pharmaceutical compounds
AU2001238346A1 (en)	2001-08-27	Modification of biopolymers for improved drug delivery
AU777185C (en)	2001-11-26	Pharmaceutical form of administration for peptides, methods for its production and use
AU7594900A (en)	2001-05-10	Pharmaceutical formulations containing poorly soluble drug substances
AU2002234545A1 (en)	2002-06-18	Pharmaceutical preparation in the form of a suspension comprising an acid-labileactive ingredient
AU2001277738A1 (en)	2002-05-23	Piperidine derivatives and drugs containing these derivatives as the active ingredient
AU2002350386A1 (en)	2003-05-19	Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel
AU4977300A (en)	2000-11-17	Pharmaceutical formulations
AU2002212863A1 (en)	2002-05-15	Stable pharmaceutical form of an anticancer drug
AU1385801A (en)	2001-04-30	Pharmaceutical formulations
AU2001260089A1 (en)	2001-12-03	Pharmaceutical compositions comprising desglymidodrine as an active drug substance
AU2002216864A1 (en)	2002-07-01	Conjugates of antibodies and anticancer drugs
AU2001295884A1 (en)	2002-04-08	Dispenser for endermic administration of drug
AU2001250625A1 (en)	2001-10-30	19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them
EP1526838B8 (en)	2013-02-06	Intravenous pharmaceutical form of administration